- Biotechnology
- Thursday, 01 Apr 2021
Europe Drug Modelling Software Market Volume Analysis, Segments, Value Share and Key Trends 2020-2027
According to our new market research study on “Europe Drug Modelling Software Market to 2027 – Regional Analysis and Forecast – by Type, and Application” the market is expected to reach US$ 3,215.94 million by 2027 from US$ 1,826.99 million in 2019; it is estimated to grow at a CAGR of 7.6% from 2020 to 2027. The report provides trends prevailing in the Europe drug modelling software market and the factors driving the market growth along with those hindering it.
In 2019, the software segment accounted for the highest share of the market. Also, the same segment is estimated to grow at the highest CAGR in the forecast period. Growth of this segment is attributed to the growing demand for effective therapeutics and increase in drug discovery efforts of various biologics across a wide range of therapeutics. In addition, strategic activities by service providers such as collaborations, product advancement, and product launch in order to expediate drug discovery timeline are further accelerating the growth of the market.
Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.theinsightpartners.com/sample/TIPRE00013989/
Company Profiles
- Crown Bioscience Inc (JSR life science)
- Genedata AG
- Biognos AB
- Dassault Systèmes
- Acellera
The growth of the Europe drug modelling software market is mainly attributed to the rapid integration of AI for the drug discovery, increasing preference for personalized medicine, high R&D spending for novel therapeutic applications and presence of major market players. However, the lack of data standardization is the major factor hindering the market growth in Europe.
Genedata AG; Biognos AB; Dassault Systèmes; Acellera; and Crown Bioscience Inc (JSR life science) are among the leading companies operating in the Europe drug modelling software market.
EUROPE DRUG MODELLING SOFTWARE MARKET SEGMENTATION
By Product Type
- Database
- Software
- Others
By Application
- Drug Discovery and Development
- Computational Physiological Medicine
- Disease Modeling
- Medical Imaging
- Predictive Analysis of Drug Targets
- Simulation Software
- Cellular Simulation
- Others
By Country
- Germany
- France
- United Kingdom
- Italy
- Spain
Purchase a copy of this research report @ https://www.theinsightpartners.com/buy/TIPRE00013989/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Related Industry Updates
US and Europe Cell and Gene Therapy Manufacturing Services Market is expected to reach US$ 16,869.1 million by 2030
Aug 10, 2023
Esoteric Testing Market Is Expected to Reach US$ 45,081.6 Million by 2025
Oct 07, 2019
South and Central America Genomics Market Insights, Scope And Forecast By 2020-2027
Mar 31, 2021
Vaccines Market is expected to reach US$ 216.30 billion by 2030
Nov 30, 2023
Efforts by Manufacturers Will Accelerate Bioreactors Market Growth
Sep 26, 2019
Respiratory Tract Infection Treatment Market – Know What Segments & Players Seeking Heavy Attention
Mar 30, 2021
Healthcare Payer Services Market to Witness Promising Growth Opportunities by 2020-2027 | Global Share, Size, Manufacturer Data, Production, Future Plans, Strategies, Deployment Model etc.
Dec 29, 2020